Molefy wins the eighth edition of the Investment Forum of the Science and Technology Park of Tenerife
Moley Pharma, a spin-off of the CSIC in collaboration 1with ARQUIMEA dedicated to finding a cure for amyotrophic lateral sclerosis (ALS) through the AP-2 molecule, has won first prize in the eighth edition of the Investment Forum of the Science and Technology Park of Tenerife. The event, held as part of the second edition of Hub Intech, […]